{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-008904","form_type":"8-K","ticker":"ENSC","cik":"0001716947","company_name":"Ensysce Biosciences, Inc.","filed_at":"2023-03-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.289165+00:00","generated_at":"2026-06-17T16:51:52.573223+00:00","sec_items":["5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Ensysce shareholders approve reverse stock split at ratio of 1:5 to 1:12","bullets":["Reverse split proposal approved with 2,836,326,468 For, 280,656,829 Against, 19,762,315 Abstain.","Board authorized to set exact ratio between 1-for-5 and 1-for-12 at its discretion.","Second proposal lacked quorum and was not voted; adjournment proposal not submitted.","Special meeting held March 23, 2023; only reverse split proposal was submitted to vote."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-008904","json":"https://secwatch.observer/filing/0001493152-23-008904.json","markdown":"https://secwatch.observer/filing/0001493152-23-008904.md","text":"https://secwatch.observer/filing/0001493152-23-008904.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1716947/000149315223008904/0001493152-23-008904-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1716947/000149315223008904/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T16:51:52.573223+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"928f6ea534dcc04c6e5cafae048e769b94f9550a","claim":"Ensysce Biosciences, Inc. shareholders approved Approve an amendment to the Certificate of Incorporation to authorize a Reverse Stock Split at a ratio of not less than one-for-five and not more than one-for-twelve at the 2023-03-23 meeting.","evidence_excerpt":"Proposal to approve an amendment to the Company’s Certificate of Incorporation to authorize the Company’s Board of Directors to combine outstanding shares of the Company’s common stock into a lesser number of outstanding shares, a “Reverse Stock Split,” by a ratio of not less than one-for-five and not more than one-for-twelve, with the exact ratio to be set within this range by the Board in its sole discretion, in the form attached as Annex A to this Proxy Statement (the “Reverse Split Proposal”): For Against Abstentions 2,836,326,468 280,656,829 19,762,315","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1716947/000149315223008904/0001493152-23-008904-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"reverse split"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-03-23"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}